Biogen (BIIB) Income Statement

Click line-items for a historical chart and %

Revenues:
Product	2.54B
Unconsolidated joint business
Other	98.6M
Total revenues	2.96B
Cost and expenses:
Cost of sales, excluding amortization of acquired intangible assets
Research and development
Selling, general and administrative	462.7M
Collaboration profit sharing
Amortization of acquired intangible assets	99.7M
Acquired in-process research and development
Restructuring charge	11.6M
Fair value adjustment of contingent consideration
Total cost and expenses	1.53B
Income from operations	1.43B
Other income (expense), net
Income before income tax expense	1.37B
Income tax expense	337M
Net income	1.03B
Net income attributable to noncontrolling interests, net of tax	-2.7M
Net income attributable to Biogen Idec Inc.	1.03B
Net income per share:
Basic earnings per share attributable to Biogen Idec Inc.	4.72
Diluted earnings per share attributable to Biogen Idec Inc.	4.71
Weighted-average shares used in calculating:
Basic earnings per share attributable to Biogen Idec Inc.	218.9M
Diluted earnings per share attributable to Biogen Idec Inc.	219.4M

Entities mentioned with BIIB